ASIX · AdvanSix Inc.
Price & Indicators
Up next
AI Brief
TL;DR.
AI-generated from the earnings call and 8-K · may contain errors · not investment advice
Ask ALVIS about this →Equibles Rating
blended score · not investment adviceBlended from price, momentum, positioning, fundamentals & volatility · daily-close · not investment advice. Market backdrop is context, not part of the score.
Guidance & track record
Guidance from company 8-Ks · delivered figures from as-reported statements · no analyst estimates involved.
Technicals
trend & momentum for long-term holders BuyIllustrative technical + ownership context — a signal mix, not investment advice.
Key metrics
the company's own KPIs, from its earnings releases, calls, and filings| Metric | Latest | Period | YoY |
|---|---|---|---|
| Adjusted EBITDA non-GAAP | $4,756K | 1Q 2026 | — |
| Adjusted EBITDA Margin % non-GAAP | 1.2% | 1Q 2026 | — |
|
|
|||
| Free Cash Flow non-GAAP | -$51,268K | 1Q 2026 | — |
Figures exactly as the company stated them · click a metric with a to chart its history · period links open the stating document · "call" marks figures stated on the earnings call, "filing" figures stated in the 10-K/10-Q · YoY needs the prior-year figure on file
Versus peers
Chemicals — same industry group| Company | Mkt cap | YTD | Rev growth Y/Y | P/E | Short % shares |
|---|---|---|---|---|---|
|
ASIX
this stock
AdvanSix Inc.
|
$550.77M | +19.1% | +45.5% | 56.8 | 2.5% |
|
SHECF
Shin-Etsu Chemical Co., Ltd.
|
$66.48B | +12.7% | — | — | 0.2% |
|
DOW
Dow Inc.
|
$20.79B | +24.9% | -7.0% | — | 4.7% |
|
NPXYY
Nippon Sanso Holdings Corporation/ADR
|
$15.96B | +20.3% | — | — | 0.0% |
|
CE
Celanese Corp
|
$4.77B | +2.9% | -7.1% | — | 7.1% |
Peers by industry group · P/E from as-reported trailing EPS · short % is of shares outstanding
At a glance
key data from every sectionPerformance
| 5D | 20D | 120D | MTD | YTD | |
|---|---|---|---|---|---|
| ASIX | +0.0% | +0.8% | +25.5% | +2.8% | +19.1% |
| SPY | -1.0% | 0.0% | +7.4% | -0.8% | +8.6% |
| vs SPY | +1.0% | +0.8% | +18.0% | +3.6% | +10.4% |
Capital returns
Dividends per share over the trailing 365 days by ex-date · buyback figures as last reported in SEC filings ("spent" derived as authorized − remaining; when several programs run concurrently, authorized is their combined total per the newest filing) · components shown separately — trailing-year buyback spend isn't tracked, so no combined shareholder yield is derived.